日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pembrolizumab and Paclitaxel in Patients with HR+/HER2- Breast Cancer with HER2-Enriched or Basal-like Subtypes

帕博利珠单抗联合紫杉醇治疗 HR+/HER2- 乳腺癌患者,包括 HER2 富集型或基底样亚型

Conte, Benedetta; Brasó-Maristany, Fara; Pascual, Tomás; Hernando, Cristina; Vázquez, Silvia; Blanch, Salvador; Oliveira, Mafalda; Virizuela, Juan Antonio; Muñoz, Montserrat; Seguí, Elia; Rodriguez-Hernandez, Adela; Vidal Losada, Maria Jesus; Galván, Patricia; Castillo, Oleguer; Blasco, Paula; Alva, Manuel; Chic, Nuria; Sanfeliu, Esther; Cano-Crespo, Sara; Salvador, Fernando; Villacampa, Guillermo; Villanueva, Lorea; Ferrero-Cafiero, Juan Manuel; Vivancos, Ana; Prat, Aleix; Ciruelos, Eva

Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial

曲妥珠单抗德鲁替康治疗HER2低表达转移性乳腺癌:随机3期DESTINY-Breast04试验的长期生存分析

Modi, Shanu; Jacot, William; Iwata, Hiroji; Park, Yeon Hee; Vidal Losada, Maria; Li, Wei; Tsurutani, Junji; Ueno, Naoto T; Zaman, Khalil; Prat, Aleix; Papazisis, Konstantinos; Rugo, Hope S; Yamashita, Toshinari; Harbeck, Nadia; Im, Seock-Ah; De Laurentiis, Michelino; Pierga, Jean-Yves; Wang, Xiaojia; Gombos, Andrea; Tokunaga, Eriko; Orbegoso Aguilar, Cecilia; Yung, Lotus; Xiao, Feng; Cheng, Yingkai; Cameron, David

Molecular characterization of pregnancy-associated breast cancer and insights on timing from GEICAM-EMBARCAM study

GEICAM-EMBARCAM 研究揭示了妊娠相关乳腺癌的分子特征及其发病时机。

Peña-Enríquez, Regina; Bermejo, Begoña; Pollán, Marina; Díaz-Chacón, Alejandra; Jerez Gilarranz, Yolanda; Ponce Lorenzo, José J; Fernández Aramburo, Antonio; Cantos Sánchez de Ibargüen, Blanca; Santaballa Bertrán, Ana; Galve-Calvo, Elena; Jiménez-Arranz, Álvaro; Fernández, Yolanda; Pérez, María Eva; De La Cruz, Susana; Anton-Torres, Antonio; Moreno, Fernando; Vidal-Losada, María Jesús; López-Ceballos, María Helena; Blancas, Isabel; Echarri, María José; Rincón, Raúl; Caballero, Rosalía; Guerrero-Zotano, Ángel; Guil-Luna, Silvia; de la Haba-Rodríguez, Juan

A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC): a pooled analysis of seven studies

早期三阴性乳腺癌 (TNBC) 中 14 个基因的 B 细胞免疫特征:七项研究的汇总分析

Conte, Benedetta; Brasó-Maristany, Fara; Hernández, Adela Rodríguez; Pascual, Tomás; Villacampa, Guillermo; Schettini, Francesco; Vidal Losada, Maria J; Seguí, Elia; Angelats, Laura; Garcia-Fructuoso, Isabel; Gómez-Bravo, Raquel; Lorman-Carbó, Natàlia; Paré, Laia; Marín-Aguilera, Mercedes; Martínez-Sáez, Olga; Adamo, Barbara; Sanfeliu, Esther; Fratini, Beatrice; Falato, Claudette; Chic, Núria; Vivancos, Ana; Villagrasa, Patricia; Staaf, Johan; Parker, Joel S; Perou, Charles M; Prat, Aleix

Unraveling the clinicopathological and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-low and HER2-0 breast cancer

揭示新辅助化疗和内分泌治疗在激素受体阳性/HER2低表达和HER2阴性乳腺癌中引起的临床病理和分子变化

Schettini, F; Nucera, S; Brasó-Maristany, F; De Santo, I; Pascual, T; Bergamino, M; Galván, P; Conte, B; Seguí, E; García Fructuoso, I; Gómez Bravo, R; Rivera, P; Rodríguez, A B; Martínez-Sáez, O; Ganau, S; Sanfeliu, E; González-Farre, B; Vidal Losada, M J; Adamo, B; Cebrecos, I; Mension, E; Oses, G; Jares, P; Vidal-Sicart, S; Mollà, M; Muñoz, M; Prat, A

SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)

SEOM-GEICAM-SOLTI早期乳腺癌临床指南(2022)

Ayala de la Peña, Francisco; Antolín Novoa, Silvia; Gavilá Gregori, Joaquín; González Cortijo, Lucía; Henao Carrasco, Fernando; Martínez Martínez, María Teresa; Morales Estévez, Cristina; Stradella, Agostina; Vidal Losada, María Jesús; Ciruelos, Eva